Entities / Company
Arbutus Biopharma.
Canadian Bio Tech Company
- Reports this week
- 2
- Active events
- 1
- Connections
- 22
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Active this week
One to three months ago
Gone quiet
No new reports in 90+ days-
Harry L.A. Janssen joined the Arbutus Scientific Advisory Board, while Anuj was appointed VP at Vertex. Janssen also maintains ties with Erasmus MC in Rotterdam.Some support2 reports
-
Arbutus Biopharma operates within the biomedical and genetics sector, and its stock performance was compared to the S&P 500.Some support2 reports
No events began in the chosen period. Widen it, or reset.
Around Arbutus Biopharma this week
News at the entities that move Arbutus Biopharma most-
MarketBeat StructuralApple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Moves Arbutus Biopharma
-
Pfizer OperationalDave Long trained at Fort Knox after graduating from Boardman High School and later worked for Pfizer.Moves Arbutus Biopharma
Connections
The 3 strongest of 22, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
MarketBeat Structural
Arbutus Biopharma utilizes MarketBeat as its financial data reporting platform.
-
Pfizer Operational
Arbutus Biopharma has initiated patent lawsuits against Pfizer.
-
Medical Shared context
Arbutus Biopharma is contextualized within the Medical sector.